In the FinnGen GWAS, there was a suggestive association between increases in genetically proxied APO-A1 levels and a decreased risk of migraine (OR = 0.90 [95% CI, 0.82–0.99]; p = 0.05) (Fig. 2, Table S11). The gene discussed is APOA1; the disease is migraine disorder.